SPARC and gastric cancer: Microarray-based bioinformatics studies revealed increased expression of CAF markers Fibronectin 1 (FN1), Serine proteinase inhibitor 1 (SERPINE1), and secreted protein acidic and cystine-rich (SPARC) genes in gastric cancer patients with low survival (Li et al., 2019).